Top Markets
Coin of the day
Harbin Pharmaceutical Group Co., Ltd. Harbin Pharmaceutical Group Co., Ltd.

Harbin Pharmaceutical Group Co., Ltd.

600664
Rank in Stocks #4980
Harbin Pharmaceutical Group Co., Ltd. functions as a leading pharmaceutical... Harbin Pharmaceutical Group Co., Ltd. functions as a leading pharmaceutical company, overseeing the complete process from drug discovery and development to manufacturing and global sales. The firm's activities span both domestic Chinese markets and international territories. Its business structure is segmented into seven key areas: Antibiotics, Small-Molecule Drug Formulations, Over-the-Counter (OTC) and Health Products, Modern Chinese Medicine, Biopharmaceutical products, Animal Vaccines, and Pharmaceutical Distribution services. The company's broad product portfolio features a comprehensive selection of penicillin and cephalosporin antibiotics, in addition to vital pharmaceutical intermediates. Its notable offerings include various types of injections, such as Shuang Huanglian and Danshen freeze-dried injections, alongside a wide array of oral medications like roxithromycin dispersible tablets, amoxicillin capsules, and specialized pediatric granules containing paracetamol. The product line also encompasses a diverse range of antibiotics, highlighted by multiple cephalosporin-based injections (e.g., ceftriaxone sodium, cefepime hydrochloride) and penicillin derivatives, alongside extracts from traditional Chinese medicine like Panax ginseng. Furthermore, the group manufactures essential medical protective gear, including disposable surgical and protective masks, as well as isolation and protective gowns. These products are distributed under numerous well-known brands, including Hongyan Yaopin, Guangwei, Renmin Tongtai, and Hayao, among others. The company's headquarters are located in Harbin, China.
Share Price
$1.23
Market Cap
$3.11B
Change (1 day)
4.03%
Change (1 year)
133.40%
Country
CN
Trade Harbin Pharmaceutical Group Co., Ltd. (600664)

Category

EPS for Harbin Pharmaceutical Group Co., Ltd. (600664)
EPS as of 2026 TTM: 0
According to Harbin Pharmaceutical Group Co., Ltd. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Harbin Pharmaceutical Group Co., Ltd. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors